Empagliflozin is a medication used primarily to treat type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which work by helping the kidneys remove excess sugar from the bloodstream through urine. This can help lower blood sugar levels and improve overall glycemic control. In addition to its effects on blood sugar, empagliflozin has been shown to provide cardiovascular benefits. Studies indicate that it may reduce the risk of heart-related complications in people with diabetes, making it an important option for managing both diabetes and heart health.